Clinical Trials Directory

Trials / Completed

CompletedNCT04167995

Assessment of Probiotics Lactobacillus in the Management of Attention Deficit Hyperactive Disorder

Assessment of Probiotic Strain Lactobacillus Acidophilus LB Supplementation as Adjunctive Management of Attention-deficit Hyperactivity Disorder in Children and Adolescents: a Randomized Controlled Clinical Trial

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
6 Years – 16 Years
Healthy volunteers
Accepted

Summary

ADHD is a neurodevelopmental disorder characterized by persistent symptoms of inattention and/or hyperactivity and impulsivity that are present before age 18. These symptoms must be evident across ADHD treatment is currently based on a multimodal approach with the combination of psychotherapy and pharmacotherapy, but no reliable markers of treatment response have been identified yet and 20-35% of subjects in clinical trials may have an inadequate response to the treatment The gut microbiome refers to the microbial ecosystem found in the gastrointestinal system of the human species Probiotics are a type of beneficial bacteria that improve health and facilitate intestinal microbial balance Increasing evidence suggests that the gut microbiota plays a key role in the gut-brain communication axis by influencing metabolism, inflammation, the hypothalamic-pituitary-adrenal axis, and neurotransmission multiple domains and cause Impairment in functioning in order to meet the diagnostic criteria for ADHD

Detailed description

All patients will be randomly distributed into two equal groups using a random number generator from computer-based randomization software. the probiotic group (n=40) received probiotic preparation twice daily (Lacteol Forte; Rameda, Egypt) as sachets containing 10 billion colony-forming units (CFU) of Lactobacillus fermentum and Lactobacillus delbruekii for 12 weeks added to a weight-dependent dose of standard treatment (Atomoxetine), and the 40 patients in the control group will not receive the probiotic and on a weight-dependent dose of atomoxetine.

Conditions

Interventions

TypeNameDescription
DRUGProbiotic Formula lacteal forteActive Comparator: Patient with attention deficit hyperactive disorder patients (n=40) will receive probiotic preparation twice daily (Lacteol Forte; Rameda, Egypt) as sachets containing 10 billion colony forming units (CFU) of Lactobacillus fermentum and Lactobacillus delbruekii for 12 weeks .

Timeline

Start date
2020-06-09
Primary completion
2020-11-09
Completion
2021-10-30
First posted
2019-11-19
Last updated
2022-12-27

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04167995. Inclusion in this directory is not an endorsement.